Colin L. Sweeney

2.1k total citations
31 papers, 1.1k citations indexed

About

Colin L. Sweeney is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Colin L. Sweeney has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 10 papers in Immunology and 6 papers in Oncology. Recurrent topics in Colin L. Sweeney's work include CRISPR and Genetic Engineering (11 papers), Pluripotent Stem Cells Research (6 papers) and CAR-T cell therapy research (6 papers). Colin L. Sweeney is often cited by papers focused on CRISPR and Genetic Engineering (11 papers), Pluripotent Stem Cells Research (6 papers) and CAR-T cell therapy research (6 papers). Colin L. Sweeney collaborates with scholars based in United States, France and Belgium. Colin L. Sweeney's co-authors include Harry L. Malech, Uimook Choi, Suk See De Ravin, Sherry Koontz, Jizhong Zou, Jason Pan, Hongmei Wang, Randall K. Merling, Bin-Kuan Chou and Linzhao Cheng and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Colin L. Sweeney

27 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Colin L. Sweeney United States 15 752 315 286 207 186 31 1.1k
Katayoun Ayasoufi United States 18 274 0.4× 467 1.5× 143 0.5× 256 1.2× 150 0.8× 39 1.0k
Xiangyun Amy Chen United States 6 507 0.7× 387 1.2× 63 0.2× 97 0.5× 53 0.3× 7 934
Stefania Merella Italy 8 484 0.6× 95 0.3× 399 1.4× 163 0.8× 64 0.3× 9 734
Melissa Vrohlings Switzerland 6 268 0.4× 800 2.5× 86 0.3× 452 2.2× 351 1.9× 11 1.2k
Oumeya Adjali France 18 759 1.0× 104 0.3× 581 2.0× 192 0.9× 41 0.2× 53 1.1k
Lisa Woodworth United States 10 381 0.5× 284 0.9× 277 1.0× 156 0.8× 100 0.5× 13 711
Ana Sevilla Spain 17 948 1.3× 84 0.3× 93 0.3× 240 1.2× 66 0.4× 33 1.3k
Xinzheng V. Guo United States 12 470 0.6× 200 0.6× 65 0.2× 220 1.1× 41 0.2× 19 830
Jeremy P. Springhorn United States 13 444 0.6× 172 0.5× 134 0.5× 101 0.5× 50 0.3× 17 936
Uimook Choi United States 22 1.1k 1.4× 478 1.5× 644 2.3× 523 2.5× 27 0.1× 44 1.7k

Countries citing papers authored by Colin L. Sweeney

Since Specialization
Citations

This map shows the geographic impact of Colin L. Sweeney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin L. Sweeney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin L. Sweeney more than expected).

Fields of papers citing papers by Colin L. Sweeney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colin L. Sweeney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin L. Sweeney. The network helps show where Colin L. Sweeney may publish in the future.

Co-authorship network of co-authors of Colin L. Sweeney

This figure shows the co-authorship network connecting the top 25 collaborators of Colin L. Sweeney. A scholar is included among the top collaborators of Colin L. Sweeney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colin L. Sweeney. Colin L. Sweeney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Linyuan, Siyuan Liu, Madelynn N. Whittaker, et al.. (2024). High-fidelity PAMless base editing of hematopoietic stem cells to treat chronic granulomatous disease. Science Translational Medicine. 16(769). eadj6779–eadj6779. 7 indexed citations
2.
Sweeney, Colin L., et al.. (2024). Biochemical Properties of Synaptic Proteins Are Dependent on Tissue Preparation: NMDA Receptor Solubility Is Regulated by the C‐Terminal Tail. Journal of Cellular Biochemistry. 126(1). e30664–e30664. 1 indexed citations
3.
Sweeney, Colin L., et al.. (2023). P25 Single- and repeat-dose nonclinical data for PGN-EDO51 demonstrate potential for the treatment of Duchenne muscular dystrophy (DMD). Neuromuscular Disorders. 33. S103–S103. 1 indexed citations
4.
Sweeney, Colin L., et al.. (2023). P27 Three novel enhanced delivery Oligonucleotide candidates for Duchenne muscular dystrophy mediate high levels of exon 53, 45, and 44 skipping. Neuromuscular Disorders. 33. S103–S104. 1 indexed citations
5.
Gao, Ji‐Liang, Alexander Yang, David H. McDermott, et al.. (2023). CRISPR/Cas9-mediated Cxcr4 Disease Allele Inactivation for Gene Therapy in a Mouse Model of WHIM Syndrome. Blood. 142(1). 23–32. 1 indexed citations
6.
Zhang, Zinan, Yu Zhang, Colin L. Sweeney, et al.. (2021). Homozygous IL37 mutation associated with infantile inflammatory bowel disease. Proceedings of the National Academy of Sciences. 118(10). 18 indexed citations
7.
Sweeney, Colin L., Mara Pavel-Dinu, Uimook Choi, et al.. (2021). Correction of X-CGD patient HSPCs by targeted CYBB cDNA insertion using CRISPR/Cas9 with 53BP1 inhibition for enhanced homology-directed repair. Gene Therapy. 28(6). 373–390. 34 indexed citations
8.
9.
Xie, Wen, et al.. (2018). Using CRISPR/Cas9 for Gene Knockout in Immunodeficient NSG Mice. Methods in molecular biology. 1874. 139–168.
10.
Arai, Yasuyuki, Uimook Choi, Sherry Koontz, et al.. (2018). Myeloid Conditioning with c-kit-Targeted CAR-T Cells Enables Donor Stem Cell Engraftment. Molecular Therapy. 26(5). 1181–1197. 37 indexed citations
11.
Sweeney, Colin L., Uimook Choi, Chengyu Liu, et al.. (2017). CRISPR-Mediated Knockout of Cybb in NSG Mice Establishes a Model of Chronic Granulomatous Disease for Human Stem-Cell Gene Therapy Transplants. Human Gene Therapy. 28(7). 565–575. 10 indexed citations
12.
Sweeney, Colin L., Jizhong Zou, Uimook Choi, et al.. (2017). Targeted Repair of CYBB in X-CGD iPSCs Requires Retention of Intronic Sequences for Expression and Functional Correction. Molecular Therapy. 25(2). 321–330. 37 indexed citations
13.
14.
Merling, Randall K., Douglas B. Kuhns, Colin L. Sweeney, et al.. (2016). Gene-edited pseudogene resurrection corrects p47phox-deficient chronic granulomatous disease. Blood Advances. 1(4). 270–278. 39 indexed citations
15.
16.
Merling, Randall K., Colin L. Sweeney, Jessica Chu, et al.. (2014). An AAVS1-Targeted Minigene Platform for Correction of iPSCs From All Five Types of Chronic Granulomatous Disease. Molecular Therapy. 23(1). 147–157. 59 indexed citations
17.
Zou, Jizhong, Colin L. Sweeney, Bin-Kuan Chou, et al.. (2011). Oxidase-deficient neutrophils from X-linked chronic granulomatous disease iPS cells: functional correction by zinc finger nuclease–mediated safe harbor targeting. Blood. 117(21). 5561–5572. 186 indexed citations
18.
Sweeney, Colin L., Miechaleen D. Diers, Joel L. Frandsen, et al.. (2002). Methotrexate Exacerbates Tumor Progression in a Murine Model of Chronic Myeloid Leukemia. Journal of Pharmacology and Experimental Therapeutics. 300(3). 1075–1084. 8 indexed citations
19.
Sweeney, Colin L., Daryl J. Murry, Karen Fife, et al.. (2001). Pharmacokinetic (PK) and pharmacodynamic analysis of aspirin administered with multi-targeted antifolate (ALIMTA). European Journal of Cancer. 37. S31–S31. 2 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katayoun Ayasoufi Breakdown of academic impact, for papers by Xiangyun Amy Chen Breakdown of academic impact, for papers by Stefania Merella Breakdown of academic impact, for papers by Melissa Vrohlings Breakdown of academic impact, for papers by Oumeya Adjali Breakdown of academic impact, for papers by Lisa Woodworth Breakdown of academic impact, for papers by Ana Sevilla Breakdown of academic impact, for papers by Xinzheng V. Guo Breakdown of academic impact, for papers by Jeremy P. Springhorn Breakdown of academic impact, for papers by Uimook Choi
Rankless by CCL
2026